Dr. Palumbo is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
9120 Double Diamond Pkwy
Reno, NV 89521- Is this information wrong?
Education & Training
George Washington University School of Medicine and Health SciencesClass of 1985, MD
Certifications & Licensure
PA State Medical License 1995 - 2022
CT State Medical License 1995 - 1998
NY State Medical License 1989 - 1998- American Board of Psychiatry and Neurology Psychiatry
Clinical Trials
- A Study for Evaluation of BIV201 to Reduce Ascites and Complications in Patients With Cirrhosis and Refractory Ascites Start of enrollment: 2021 Jun 17
Publications & Presentations
PubMed
- 86 citationsEfficacy and safety of OROS methylphenidate in adults with attention-deficit/hyperactivity disorder: a randomized, placebo-controlled, double-blind, parallel group, do...Lenard A. Adler, Brenda Zimmerman, H. Lynn Starr, Steve Silber, Joseph Palumbo
Journal of Clinical Psychopharmacology. 2009-06-01 - 36 citationsLong-term safety of OROS methylphenidate in adults with attention-deficit/hyperactivity disorder: an open-label, dose-titration, 1-year study.Lenard A. Adler, Camille Orman, H. Lynn Starr, Steve Silber, Joseph Palumbo
Journal of Clinical Psychopharmacology. 2011-02-01 - 21 citationsPost-hoc analysis of randomised, placebo-controlled, double-blind study (MCI186-19) of edaravone (MCI-186) in amyotrophic lateral sclerosisKoji Takei, Fumihiro Takahashi, Shawn Liu, Kikumi Tsuda, Joseph Palumbo
Amyotrophic Lateral Sclerosis & Frontotemporal Degeneration. 2017-09-05
Press Mentions
BioVie : Regulation FD Presentation - Form 8-KJuly 5th, 2022
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
